Pfizer saw U.S. Comirnaty sales drop to $870 million in the recently completed third quarter from $1.16 billion in the same time frame last year. That came after vaccine sales rose the first two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback